Jonathan Glass - Profile and Journalist Details

Beats

Content

Total articles 20

• Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration - Nature Communications

  By Alfredo Iacoangeli, Simon D. Topp, Puja R Mehta, Naomi Limbachiya, Kelly Williams, Wade K. Self, Lyndal Henden, Garth A. Nicholson, Nicola Ticozzi, Pamela Shaw, John Landers, Jonathan Glass, Jesus Mora, Philip Van Damme, Russell McLaughlin, Jan H. Veldink, William Camu, Teepu Siddique, Robert Brown, Ammar Al-Chalabi, Ahmad Al-Khleifat| Nature Verified Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34620-y, published online 12 November 2022The original version of this Article contained an error in Figure 4. Under the heading ‘Disease duration (months)’, all disease durations were reported as ‘disease duration’ rather than reporting the numerical value. The correct version now reports the disease duration in months instead of the original, incorrect ‘disease duration’.

  By Alfredo Iacoangeli, Simon D. Topp, Puja R Mehta, Naomi Limbachiya, Kelly Williams, Wade K. Self, Lyndal Henden, Garth A. Nicholson, Nicola Ticozzi, Pamela Shaw, John Landers, Jonathan Glass, Jesus Mora, Philip Van Damme, Russell McLaughlin, Jan H. Veldink, William Camu, Teepu Siddique, Robert Brown, Ammar Al-Chalabi, Ahmad Al-Khleifat · Nature

  Jul. 02, 2024

• Unintended Consequences of Approving Unproven Treatments

  By Jonathan Glass, Christina N. Fournier| JAMA (The Journal of the American Medical Association) Verified Original Investigation Safety and Effectiveness of Long-term Intravenous Edaravone Therapy for Amyotrophic Lateral Sclerosis Simon Witzel, MD; André Maier, MD; Robert Steinbach, MD; Julian Grosskreutz, MD; Jan C. Koch, MD; Anastasia Sarikidi, MD; Susanne Petri, MD; René Günther, MD; Joachim Wolf, MD; Andreas Hermann, MD; Johannes Prudlo, MD; Isabell Cordts, MD; Paul Lingor, MD; Wolfgang N.

  By Jonathan Glass, Christina N. Fournier · JAMA (The Journal of the American Medical Association)

  Jan. 10, 2022

• Author Correction: The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration - Nature Communications

  By Alfredo Iacoangeli, Simon D. Topp, Puja R Mehta, Naomi Limbachiya, Kelly Williams, Wade K. Self, Lyndal Henden, Garth A. Nicholson, Nicola Ticozzi, Pamela Shaw, John Landers, Jonathan Glass, Jesus Mora, Philip Van Damme, Russell McLaughlin, Jan H. Veldink, William Camu, Teepu Siddique, Robert Brown, Ammar Al-Chalabi, Ahmad Al-Khleifat| Nature Verified Correction to: Nature Communications https://doi.org/10.1038/s41467-022-34620-y, published online 12 November 2022The original version of this Article contained an error in Figure 4. Under the heading ‘Disease duration (months)’, all disease durations were reported as ‘disease duration’ rather than reporting the numerical value. The correct version now reports the disease duration in months instead of the original, incorrect ‘disease duration’.

  By Alfredo Iacoangeli, Simon D. Topp, Puja R Mehta, Naomi Limbachiya, Kelly Williams, Wade K. Self, Lyndal Henden, Garth A. Nicholson, Nicola Ticozzi, Pamela Shaw, John Landers, Jonathan Glass, Jesus Mora, Philip Van Damme, Russell McLaughlin, Jan H. Veldink, William Camu, Teepu Siddique, Robert Brown, Ammar Al-Chalabi, Ahmad Al-Khleifat · Nature

  Jul. 02, 2024

As seen in

Company Info

Bulletin of The Royal College of Surgeons of England